Sign in
4

Changes in Ownership

NeuroSense Therapeutics Ltd. Filed Acc 0001213900-26-069662

Chief Financial Officer bought 250,000 shares at $0.80 ($200,000)

From the SEC's structured data for this filing

Trades in this filing

Eisenberg Or · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-06-16 Purchase : show line 1 in the form +250,000 $0.80 $200,000 1,504,050 D
Open-market purchases · 250,000 sh · avg $0.80 · $200,000
Loading xslF345X06/ownership.xml…